197.14 0.00 (0.00%)
After hours: 5:05PM EDT
|Bid||197.02 x 1000|
|Ask||197.09 x 1000|
|Day's Range||195.39 - 198.75|
|52 Week Range||144.75 - 198.75|
|Beta (3Y Monthly)||1.04|
|PE Ratio (TTM)||21.11|
|Earnings Date||Apr 24, 2019 - Apr 29, 2019|
|Forward Dividend & Yield||2.08 (1.07%)|
|1y Target Est||193.50|
Stryker Joint Replacement is using its knee surgery technology to help surgeons “hit the target of where implants should be with accuracy and precision.” Yahoo Finance’s Alexis Christoforous speaks to Robert Cohen, Stryker Joint Replacement Chief Technology Officer.
Kalamazoo, Michigan, March 20, 2019 -- Stryker (NYSE:SYK) announced its 2019 Annual Meeting of Shareholders is scheduled as follows: May 1, 2019 – 2:00 p.m. Eastern.
The key growth-driving factor for Stryker (SYK) in the past year has been increasing net sales from each of its three major business segments.
Stryker (SYK) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Sen. John “Jack” Reed disclosed Tuesday that he sold (AAPL) stock and shares of some other high-profile tech names in late February. The Rhode Island Democrat, who serves on several committees, including Appropriations, Armed Services, and Banking, Housing, and Urban Affairs, sold Apple stock (ticker: AAPL) and shares of (XLNX) (XLNX) and (QCOM) (QCOM). The sales disclosed were all made on Feb. 28, according to a regulatory form Reed filed.
If you're looking for a profitable portfolio of stocks that will offer the best of value and growth investing, try the growth at a reasonable price or GARP strategy.
Let's talk about the popular Stryker Corporation (NYSE:SYK). The company's shares led the NYSE gainers with a relatively large price hike in the past couple of weeks. With many analystsRead More...
Strong international presence and an acquisition-driven strategy are likely to fortify Stryker's (SYK) footprint in the global MedTech space.
Stryker (SYK) announced today it has completed the acquisition of OrthoSpace, Ltd., a privately held company founded in 2009 and headquartered in Caesarea, Israel, in an all cash transaction for an upfront payment of $110 million and future milestone payments of up to an additional $110 million. OrthoSpace’s product portfolio provides a highly differentiated technology for the treatment of massive irreparable rotator cuff tears. The technology has a long clinical history with over 20,000 patients treated across 30 countries.
Stryker Corp NYSE:SYKView full report here! Summary * Bearish sentiment is low Bearish sentimentShort interest | PositiveShort interest is extremely low for SYK with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting SYK. Money flowETF/Index ownership | NeutralETF activity is neutral. ETFs that hold SYK had net inflows of $3.54 billion over the last one-month. While these are not among the highest inflows of the last year, the rate of inflow is increasing. Economic sentimentPMI by IHS Markit | NeutralAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to email@example.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
Meetings with Stryker Corporation’s (NYSE: SYK ) CEO inspired greater confidence in the company’s topline growth being sustainable into the foreseeable future, as well as near- and medium-term cost-saving ...
Zacks.com featured highlights include: Oaktree Capital, Synopsys, Starbucks, Stryker and Ares Capital
Zacks.com featured highlights include: Core-Mark, Progressive, Casey???s, Stryker and Intuit
Stryker Corporation (SYK) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.
Sales growth is an important metric for any company as it is a vital part of growth projections and is instrumental in strategic decision-making.
The Fed's shift to a patient approach on interest rates after lifting-off rates for three years has brought back the lure for dividend investing this year.
NEW YORK, March 04, 2019 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.
The big shareholder groups in Stryker Corporation (NYSE:SYK) have power over the company. Insiders often own a large chunk of younger, smaller, companies while huge companies tend to have institutionsRead More...